Skip to main content
editorial
. 2017 Oct 9;8(53):90620–90621. doi: 10.18632/oncotarget.21674

Figure 1.

Figure 1

Activated NF-κB in JEV infection induces miR-301a, which weakens IFN-β response through suppression of IRF1 and SOCS5.